Lycopene and Risk of Prostate Cancer
暂无分享,去创建一个
Xinghuan Wang | D. Negi | Ping Chen | Xinhua Zhang | Xiao Wang | Wenhao Zhang | K. Zhao | Lily T Zhuo | Mao Qi
[1] C. Mathers,et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.
[2] Jie He,et al. Annual report on status of cancer in China, 2011. , 2015, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.
[3] F. Hamdy,et al. Estimating age and ethnic variation in the histological prevalence of prostate cancer to inform the impact of screening policies , 2014, International journal of urology : official journal of the Japanese Urological Association.
[4] Stacey A. Kenfield,et al. Plasma Antioxidants, Genetic Variation in SOD2, CAT, GPX1, GPX4, and Prostate Cancer Survival , 2014, Cancer Epidemiology, Biomarkers & Prevention.
[5] M. Loda,et al. Dietary lycopene, angiogenesis, and prostate cancer: a prospective study in the prostate-specific antigen era. , 2014, Journal of the National Cancer Institute.
[6] Q. Ding,et al. Obesity has multifaceted impact on biochemical recurrence of prostate cancer: a dose–response meta-analysis of 36,927 patients , 2014, Medical Oncology.
[7] P. Tugwell,et al. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .
[8] Li Changlin,et al. Analysis of the status and trends of prostate cancer incidence in China , 2013 .
[9] Lishi Zhang,et al. Lycopene/tomato consumption and the risk of prostate cancer: a systematic review and meta-analysis of prospective studies. , 2013, Journal of nutritional science and vitaminology.
[10] V. Freeman,et al. Diet adherence dynamics and physiological responses to a tomato product whole-food intervention in African–American men , 2012, British Journal of Nutrition.
[11] Chih-min Yang,et al. Lycopene inhibits angiogenesis both in vitro and in vivo by inhibiting MMP-2/uPA system through VEGFR2-mediated PI3K-Akt and ERK/p38 signaling pathways. , 2012, Molecular nutrition & food research.
[12] Nicola Orsini,et al. Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. , 2012, American journal of epidemiology.
[13] A. Cooper,et al. Lycopene inhibits angiogenesis in human umbilical vein endothelial cells and rat aortic rings , 2011, British Journal of Nutrition.
[14] C. Soskolne,et al. Oxidative balance score and risk of prostate cancer: results from a case-cohort study. , 2011, Cancer epidemiology.
[15] Chih-min Yang,et al. Growth inhibitory efficacy of lycopene and β-carotene against androgen-independent prostate tumor cells xenografted in nude mice. , 2011, Molecular nutrition & food research.
[16] R. V. van Breemen,et al. Antioxidant Effects of Lycopene in African American Men with Prostate Cancer or Benign Prostate Hyperplasia: A Randomized, Controlled Trial , 2011, Cancer Prevention Research.
[17] I. Thompson,et al. Serum Lycopene Concentration and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial , 2011, Cancer Epidemiology, Biomarkers & Prevention.
[18] I. Thompson,et al. Diet, supplement use, and prostate cancer risk: results from the prostate cancer prevention trial. , 2010, American journal of epidemiology.
[19] J. Beilby,et al. Serum levels of folate, lycopene, β-carotene, retinol and vitamin E and prostate cancer risk , 2010, European Journal of Clinical Nutrition.
[20] M. Vasson,et al. Differential effects of lycopene consumed in tomato paste and lycopene in the form of a purified extract on target genes of cancer prostatic cells. , 2010, The American journal of clinical nutrition.
[21] Dan Jackson,et al. Extending DerSimonian and Laird's methodology to perform multivariate random effects meta‐analyses , 2009, Statistics in medicine.
[22] T. Nurmi,et al. Serum lycopene and the risk of cancer: the Kuopio Ischaemic Heart Disease Risk Factor (KIHD) study. , 2009, Annals of epidemiology.
[23] Alex J Sutton,et al. Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry. , 2008, Journal of clinical epidemiology.
[24] J. Pierce,et al. The Men's Eating and Living (MEAL) study: a Cancer and Leukemia Group B pilot trial of dietary intervention for the treatment of prostate cancer. , 2008, Urology.
[25] D. Mackerras,et al. Dietary patterns identified using factor analysis and prostate cancer risk: a case control study in Western Australia. , 2008, Annals of epidemiology.
[26] J. Pierce,et al. Dietary modification in patients with prostate cancer on active surveillance: a randomized, multicentre feasibility study , 2008, BJU international.
[27] F. Berrino,et al. Plasma carotenoids, retinol, and tocopherols and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition study. , 2007, The American journal of clinical nutrition.
[28] P. Trumbo,et al. The U.S. Food and Drug Administration's evidence-based review for qualified health claims: tomatoes, lycopene, and cancer. , 2007, Journal of the National Cancer Institute.
[29] Nilanjan Chatterjee,et al. Serum Lycopene, Other Carotenoids, and Prostate Cancer Risk: a Nested Case-Control Study in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial , 2007, Cancer Epidemiology Biomarkers & Prevention.
[30] M. Pike,et al. Prostate cancer incidence and intake of fruits, vegetables and related micronutrients: the multiethnic cohort study* (United States) , 2006, Cancer Causes & Control.
[31] J. Lovato,et al. Phase I-II prospective dose-escalating trial of lycopene in patients with biochemical relapse of prostate cancer after definitive local therapy. , 2006, Urology.
[32] P. Clark,et al. Complementary and alternative medicine for advanced prostate cancer. , 2006, The Urologic clinics of North America.
[33] Sander Greenland,et al. Generalized Least Squares for Trend Estimation of Summarized Dose–response Data , 2006 .
[34] R. Hayes,et al. A Prospective Study of Lycopene and Tomato Product Intake and Risk of Prostate Cancer , 2006, Cancer Epidemiology Biomarkers & Prevention.
[35] S. Saxena,et al. Lycopene as a chemopreventive agent in the treatment of high-grade prostate intraepithelial neoplasia. , 2005, Urologic oncology.
[36] P. Riso,et al. What are typical lycopene intakes? , 2005, The Journal of nutrition.
[37] Andy H. Lee,et al. Do dietary lycopene and other carotenoids protect against prostate cancer? , 2005, International journal of cancer.
[38] M. Etminan,et al. The role of tomato products and lycopene in the prevention of prostate cancer: a meta-analysis of observational studies. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[39] John W Erdman,et al. Plasma and Dietary Carotenoids, and the Risk of Prostate Cancer , 2004, Cancer Epidemiology Biomarkers & Prevention.
[40] D. English,et al. Foods, nutrients and prostate cancer , 2004, Cancer Causes & Control.
[41] R. Goldbohm,et al. A prospective cohort study on intake of retinol, vitamins C and E, and carotenoids and prostate cancer risk (Netherlands) , 2004, Cancer Causes & Control.
[42] G. Omenn,et al. The association between lung and prostate cancer risk, and serum micronutrients: results and lessons learned from beta-carotene and retinol efficacy trial. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[43] A. Alberg,et al. Prospective study of antioxidant micronutrients in the blood and the risk of developing prostate cancer. , 2003, American journal of epidemiology.
[44] P. Bowen,et al. Tomato Sauce Supplementation and Prostate Cancer: Lycopene Accumulation and Modulation of Biomarkers of Carcinogenesis , 2002, Experimental biology and medicine.
[45] Mousumi Banerjee,et al. Effects of Lycopene Supplementation in Patients with Localized Prostate Cancer , 2002, Experimental biology and medicine.
[46] S. Thompson,et al. Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.
[47] R. Hayes,et al. Serum lycopene, other serum carotenoids, and risk of prostate cancer in US Blacks and Whites. , 2002, American journal of epidemiology.
[48] E. Rimm,et al. A prospective study of tomato products, lycopene, and prostate cancer risk. , 2002, Journal of the National Cancer Institute.
[49] C. Cordon-Cardo,et al. Inverse associations between plasma lycopene and other carotenoids and prostate cancer. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[50] S Duval,et al. Trim and Fill: A Simple Funnel‐Plot–Based Method of Testing and Adjusting for Publication Bias in Meta‐Analysis , 2000, Biometrics.
[51] I. Olkin,et al. Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .
[52] R. Jackson,et al. Prostate cancer and dietary carotenoids. , 2000, American journal of epidemiology.
[53] J. Stanford,et al. Fruit and vegetable intakes and prostate cancer risk. , 2000, Journal of the National Cancer Institute.
[54] G R Howe,et al. Plant foods, antioxidants, and prostate cancer risk: findings from case-control studies in Canada. , 1999, Nutrition and cancer.
[55] A. Ronco,et al. Foods, nutrients and prostate cancer: a case–control study in Uruguay , 1999, British Journal of Cancer.
[56] W. Willett,et al. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. , 1999, Cancer research.
[57] G. Smith,et al. Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.
[58] D. Bishop,et al. A case-control study of diet and prostate cancer. , 1997, British Journal of Cancer.
[59] G. Stemmermann,et al. Serum micronutrients and prostate cancer in Japanese Americans in Hawaii. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[60] G A Colditz,et al. Intake of carotenoids and retinol in relation to risk of prostate cancer. , 1995, Journal of the National Cancer Institute.
[61] C. Begg,et al. Operating characteristics of a rank correlation test for publication bias. , 1994, Biometrics.
[62] S. Greenland,et al. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. , 1992, American journal of epidemiology.
[63] I Yoshimura,et al. The effect of measurement error on the dose-response curve. , 1990, Environmental health perspectives.
[64] B. Polk,et al. Serologic precursors of cancer. Retinol, carotenoids, and tocopherol and risk of prostate cancer. , 1990, Journal of the National Cancer Institute.
[65] F. Harrell,et al. Regression models in clinical studies: determining relationships between predictors and response. , 1988, Journal of the National Cancer Institute.